CCL18 and melanoma: Another recent study analyzed 84 genes involved in cancer-related inflammation and immune response and highlighted a greater magnitude of the fold change in the CC chemokine ligand 18 (CCL18) gene (C-C motif) in plasma circulating cell free messenger ribonucleic acid from patients with melanoma with high disease burden, compared to those with low disease burden.